Please login to the form below
AMR
This page shows the latest AMR news and features for those working in and with pharma, biotech and healthcare.
Shionogi Europe and NHS England agree on antibiotic subscription model
continued ability to provide other healthcare – such as chemotherapy and surgical procedures – that might otherwise be compromised by increasing antimicrobial resistance (AMR). ... If the issue is left unaddressed, AMR is predicted to result in ten
Latest news
-
NHS to offer two new treatments for drug-resistant superbugs as part of a new subscription-style payment plan
to develop effective drugs against antimicrobial resistance (AMR). ... AMR-related infections have resulted in 12, 000 deaths in people living in the UK alone, and cause the deaths of more than a million people globally every year.
-
Longitude Prize in final stage of deciding recipients of £8m prize
The test will help to support treatment decisions, reduce overuse of antibiotics and confront the rising issue of antimicrobial resistance (AMR). ... It is understood that AMR diagnostic tests could save at least 333, 000 lives a year, particularly in low
-
The IMC unites health industry professionals to combat antibiotic resistant infections
The White Paper builds on the findings published in The Lancet’s worldwide report on the burden of AMR, and underscores the ways society must collectively commit to delivering transformational change. ... The IMC has called for the development of
-
Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics
Last year, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) joined forces with leading pharma and biotech companies to launch the AMR Action Fund. ... In February, the AMR Action Fund raised a further $140m from new
-
AMR Action Fund raises $140m from new investors to tackle antimicrobial resistance
The AMR Action Fund, launched last year, has raised $140m from new investors to bolster its efforts to bring new antibiotics through the clinical pipeline to patients. ... to address," said Henry Skinner, chief executive office of the AMR Action Fund.
More from news
Approximately 11 fully matching, plus 30 partially matching documents found.
Latest Intelligence
-
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
However, the AMR Action Fund is not the permanent solution to the AMR threat. ... Only through collaboration will we safeguard our future and prevent an AMR crisis.
-
Rethinking our approach to infectious disease preparedness
We are also actively looking for other new opportunities in antiviral therapeutics and AMR drugs over the next year. ... Peter Jackson, executive director, Infex Therapeutics (previously the AMR Centre). 24th November 2020.
-
How COVID-19 is accelerating the threat of antimicrobial resistance
The World Health Organization (WHO) states that antimicrobial resistance (AMR) is a global concern. ... A pharmacist in the UK echoed this sentiment, expressing that he could not sense the urgency about AMR right now.
-
The global antibiotic crisis: a 2020 perspective
market reform to address the payment problem at the heart of the AMR sector. ... saving AMR drugs sparingly to avoid widespread emergence of new drug-resistant infections.
-
Tackling antimicrobial resistance on multiple fronts
An urgent change of direction is needed in how we respond to AMR. ... Why not an international AMR Fund to support uptake of products to tackle AMR too?
More from intelligence
Approximately 1 fully matching, plus 9 partially matching documents found.
Latest appointments
-
Henry Skinner has been appointed as the first CEO of the AMR Action Fund
I am honoured to join the AMR Action Fund and its incredibly important mission. ... I am proud and excited to lead the AMR Action Fund in its efforts to tackle the global challenge of AMR.
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
Natl Geogr Mag. May 2015. https://www.nationalgeographic.com/science/article/oneill-amr-3. Accessed June 10, 2021. 28.
-
Antibiotic resistance: The silent pandemic
Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/784894/UK_AMR_5_year_national_action_plan.pdf. Accessed November 2019. Health Europa. Rapid diagnostic
-
Mobilising the public to combat the antimicrobial resistance crisis
Her illness is due to antimicrobial resistance (AMR) and it is not as rare as you might think. ... Meaning close to a quarter of patients gain no medical benefit from antibiotics – they merely contribute to increased AMR.
-
Antibiotic Resistance: Alarm bells ring louder than ever
where antibiotics and the threat of antimicrobial resistance (AMR) became a hot topic in the mainstream media. ... How can this be prevented? AMR is a complex, global issue and corrective action is only possible if we accurately know and understand what
-
amr
amr is a full-service market research agency and we are passionate about the research that we do.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- NHS App to revolutionise digital health and care with major digital updates by 2023
- A new era for UK-Japanese scientific research relations
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
PMHub
JPA Health
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
